CASE REPORT
A coexistência de glioblastoma (GBM) e meningioma é um achado raro. O glioblastoma é o tumor cerebral primário mais agressivo em adultos, enquanto o meningioma, geralmente benigno, apresenta crescimento lento. Este estudo apresenta o caso de uma paciente de 69 anos diagnosticada com ambas as neoplasias, confirmadas por análise histopatológica e imuno-histoquímica após ressecção cirúrgica. A literatura sugere diversas hipóteses para essa ocorrência, incluindo predisposição genética, influências microambientais e possíveis mecanismos compartilhados de sinalização celular. Apesar das diferentes origens e prognósticos, a presença simultânea desses tumores representa um desafio diagnóstico e terapêutico.
The coexistence of glioblastoma (GBM) and meningioma is a rare finding. The glioblastoma is the most aggressive primary brain tumor in adults, while meningioma, which is usually benign, is slow growing. This study presents the case of a 69-year-old patient diagnosed with both neoplasms, confirmed by histopathological and immunohistochemical analysis after surgical resection. The literature suggests several hypotheses for this occurrence, including genetic predisposition, microenvironmental influences and possible shared cellular signaling mechanisms. Despite the different origins and prognoses, the simultaneous presence of these tumors represents a diagnostic and therapeutic challenge.
1. Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-oncol. 2021;23(8):1231-51. http://doi.org/10.1093/neuonc/noab106. PMid:34185076.
2. Fernandes RT, Teixeira GR, Mamere EC, Bandeira GA, Mamere AE. The 2021 World Health Organization classification of gliomas: an imaging approach. Radiol Bras. 2023;56(3):157-61. PMid:37564083.
3. Godoy LFS, Paes VR, Ayres AS, et al. Advances in diffuse glial tumors diagnosis. Arq Neuropsiquiatr. 2023;81(12):1134-45. http:// doi.org/10.1055/s-0043-1777729. PMid:38157879.
4. Hanna C Jr, Willman M, Cole D, et al. Review of meningioma diagnosis and management. Egypt J Neurosurg. 2023;38(1):16. http:// doi.org/10.1186/s41984-023-00195-z.
5. Goldbrunner R, Minniti G, Preusser M, et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol. 2016;17(9):e38391. http://doi.org/10.1016/S1470-2045(16)30321-7. PMid:27599143.
6. Atallah O, Almealawy YF, Awuah WA, Conti A, Chaurasia B. Is simultaneous occurrence of meningioma and glioblastoma a mere coincidence? Clin Neurol Neurosurg. 2024;236:108099. http:// doi.org/10.1016/j.clineuro.2023.108099. PMid:38215500.
7. Feiring EH, Davidoff LM. Two tumors, meningioma and glioblastoma multiforme, in one patient. J Neurosurg. 1947;4(3):282-9. http:// doi.org/10.3171/jns.1947.4.3.0282. PMid:20239786.
8. Wang Z, Sun S, Xie K, Miao J. Glioblastoma in the contralateral cerebral hemisphere with previous surgery for meningioma: a case report. Medicine. 2023;102(1):e32616. http://doi.org/10.1097/ MD.0000000000032616. PMid:36607853.
9. Fisher RG. Intracranial meningioma followed by a malignant glioma.
J Neurosurg. 1968;29(1):83-6. http://doi.org/10.3171/jns.1968.29.1.0083.
PMid:5674096.
10. Spallone A, Santoro A, Palatinsky E, et al. Intracranial meningiomas associated with glial tumours: a review based on 54 selected literature cases from the literature and 3 additional personal cases. Acta Neurochir. 1991;110(3-4):133-9. http://doi.org/10.1007/BF01400681. PMid:1927605.
11. Dabboucy B, Younes P, Rahbani A, Fahed E, Abadjian G. Primary extra-axial glioblastoma: case report and literature review. Arq Bras Neurocir. 2021;40(4):e368-73. http://doi.org/10.1055/s-0041-1730373.
12. Scharrer E, Brunngraber CV. Uber multiple meningeome. Syndromgenetischer beitrag zur frage: systemerkrankung oder metastasierung? J Neurol. 1974;207(3):227-46. http://doi.org/10.1007/ BF00312563. PMid:4137440.
1Serviço de Neurocirurgia do Hospital Criança Conceição, Grupo Hospitalar Conceição, Porto Alegre, RS, Brazil.
2Universidade de Caxias do Sul, Caxias do Sul, RS, Brazil.
Received May 13, 2025
Accepted Jun 4, 2025